Clinical Trials Logo
  1. Home
  2. Coronary Disease
  3. NCT01184352
  4. Details
NCT01184352 Clinical Trial

Glider PTCA Balloon Catheter Registry

Coronary Disease Clinical Trial

Official title:
Registry for PCI With the TriReme Medical, Inc. Glider(TM) PTCA Balloon Catheter

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01184352
Other study ID # CLR734
Secondary ID
Status Completed
Phase N/A
First received August 16, 2010
Last updated December 5, 2012
Start date July 2010
Est. completion date September 2012

Study information
Verified date December 2012
Source TriReme Medical, LLC
Contact n/a
Is FDA regulated No
Health authority United Kingdom: Research Ethics Committee
Study type Observational

Clinical Trial Summary

The objective of this Registry is to demonstrate the utility of the Glider PTCA Balloon Catheter for crossing during the treatment of coronary artery disease.

Recruitment information / eligibility
Status Completed
Enrollment 125
Est. completion date September 2012
Est. primary completion date September 2012
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients undergoing PCI who are at least 18 years old

- PCI procedure included the use of at least one Glider PTCA Balloon Catheter

- Patient has been informed, in accordance with local requirements, that their data will be used in the Glider Registry

Exclusion Criteria:

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

Intervention

Device:
• TriReme Medical, Inc. Glider(TM) PTCA Balloon Catheter
Percutaneous Coronary Interventions performed with the Glider PTCA Balloon Catheter

Locations
Country Name City State
Germany Vivantes Klinikum Zum Friedrichshain Berlin
Germany Klinikum Coburg Herzkatheterlabor Coburg
Germany Alfried Krupp Khs Essen
Germany Elisabeth-Krankenhaus Essen Kardiologie Essen
Germany University Klinikum Muenster Muenster
United Kingdom Royal Brompton Hospital London

Sponsors (1)
Lead Sponsor Collaborator
TriReme Medical, LLC

Countries where clinical trial is conducted

Germany,  United Kingdom, 

Outcome
Type Measure Description Time frame Safety issue
Primary Technical Success Percentage of lesions successfully crossed among those attempted with the Glider PTCA Balloon Catheter as assesed during procedure. average of 1 hour No
Secondary Procedure Success Percentage of patients treated with at least one Glider PTCA Balloon Catheter having <50% residual diameter stenosis, or TIMI 3 flow if at a bifurcation side branch, without the development of in-hospital MACE (Major Adverse Cardiac Event). average of 2 days Yes
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Completed NCT05672862 - International Post-PCI FFR Extended Registry
Completed NCT04492423 - VerifyNow® PRUTest® Cardiovascular Population Expected Values On-Drug Study
Completed NCT01205776 - EXCEL Clinical Trial N/A
Recruiting NCT01218776 - International Survey of Acute Coronary Syndromes in Transitional Countries
Completed NCT00046410 - Comparison of the Risk of Stroke With On- Versus Off-Pump Coronary Artery Bypass Grafting N/A
Recruiting NCT04390672 - Multivessel TALENT N/A
Not yet recruiting NCT02895009 - Hemostatic Compression Patterns After Transradial Coronary Intervention N/A
Completed NCT02948517 - Time Restricted Feeding for Weight Loss and Cardio-protection N/A
Completed NCT02784873 - High Intensity Interval Training in UK Cardiac Rehabilitation Programmes N/A
Recruiting NCT02859480 - Dose-dependent Effect of Rosuvastatin on Long-term Clinical Outcomes After PCI Phase 4
Withdrawn NCT02418143 - A Study to Obtain Additional Information on the Use of CorMatrix® CanGaroo ECM® Envelope
Completed NCT02510547 - Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial Phase 4
Completed NCT02382731 - Interventions to Support Long-Term Adherence aNd Decrease Cardiovascular Events Post-Myocardial Infarction N/A
Recruiting NCT01681381 - Evaluate Safety And Effectiveness Of The Tivoli® DES and The Firebird2® DES For Treatment Coronary Revascularization N/A
Completed NCT02248415 - Administration of Warm Blood Cardioplegia With or Without Roller Pump N/A
Recruiting NCT01207167 - Mediators of Atherosclerosis in South Asians Living in America
Completed NCT02088138 - Functional Electrical Stimulation in Cardiac Patients N/A
Completed NCT02173067 - Anesthesia With Epinephrine in Diabetes Patients is Safe and Effective N/A
Completed NCT02133807 - Specific Lp(a) Apheresis for Regression of Coronary and Carotid Atherosclerosis Phase 3